Fifth Lane Capital »

Revance Therapeutics shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $156k 30k 5.19

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Southwestern Energy Company
Endeavor Group Hldgs Cl A Com (EDR)
Albertsons Cos Common Stock (ACI)
Envestnet (ENV)
SITE Centers Corp
Smartsheet Com Cl A (SMAR)
Monolithic Power Systems (MPWR)
Sbny 5.0 31 Dec 2049 A - P Common Shares (SBNYL)
Select Sector Spdr Tr Indl (XLI)
Ansys (ANSS)
Applovin Corp Com Cl A (APP)
Loar Holdings Com Shs (LOAR)
Ultragenyx Pharmaceutical (RARE)

View all positions for Fifth Lane Capital

Top funds holding Revance Therapeutics

BlackRock
BlackRock
Vanguard Group
Franklin Resources
Alpine Associates Management
Magnetar Financial
Tang Capital Management
Geode Capital Management
State Street Corporation
LMR Partners
D. E. Shaw & Co
Omni Event Management
Palo Alto Investors
CNH Partners
Gabelli Funds

View all funds holding Revance Therapeutics